10 Results for "

serotoninergic

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "serotoninergic" in MCE Product Catalog:

10
10 Cited Publications
Cat. No.: HY-121203
CAS No.: 59729-33-8
Purity:  99.76%
Target:  

Serotonin Transporter

Research Areas:  

Neurological Disease Cancer

Citalopram is a racemate mixture of the active S(+)-enantiomer (Escitalopram; HY-14258) and R(-)-enantiomer. Citalopram is an orally active selective serotonin reuptake inhibitor (SSRI). Citalopram is an antidepressant and enhances serotoninergic neurotransmission .
loading...
    loading...
Cat. No.: HY-P1303
CAS No.: 210978-19-1
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

CART(62-76)(human,rat) is a neuropeptide (62-76 residues of the CART peptide) with neurotransmitter-like effects. CART(62-76)(human,rat) can modulate the activity of striatal noradrenergic and corticostriatal and hypothalamic serotoninergic (5-HT) system in the rat brain .
loading...
    loading...
Cat. No.: HY-101050
CAS No.: 85181-40-4
Purity:  99.92%
Synonyms: MDL 72422
Target:  

5-HT Receptor

Research Areas:  

Cardiovascular Disease

Tropanserin is a serotoninergic active compound, as well as a 5HT3 receptor antagonist. Tropanserin modulates Cardio-respiratory reflex effects of an exogenous serotonin challenge .
loading...
    loading...
Cat. No.: HY-121203S4
Citalopram-d3 hydrochloride is deuterated labeled Citalopram (HY-121203). Citalopram is a racemate mixture of the active S(+)-enantiomer (Escitalopram; HY-14258) and R(-)-enantiomer. Citalopram is an orally active selective serotonin reuptake inhibitor (SSRI). Citalopram is an antidepressant and enhances serotoninergic neurotransmission .
loading...
    loading...
Cat. No.: HY-P1303A
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

CART(62-76)(human,rat) TFA is a neuropeptide (62-76 residues of the CART peptide) with neurotransmitter-like effects. CART(62-76)(human,rat) TFA can modulate the activity of striatal noradrenergic and corticostriatal and hypothalamic serotoninergic (5-HT) system in the rat brain .
loading...
    loading...
Cat. No.: HY-121203R
CAS No.: 59729-33-8
Citalopram (Standard) is the analytical standard of Citalopram. This product is intended for research and analytical applications. Citalopram is a racemate mixture of the active S(+)-enantiomer (Escitalopram; HY-14258) and R(-)-enantiomer. Citalopram is an orally active selective serotonin reuptake inhibitor (SSRI). Citalopram is an antidepressant and enhances serotoninergic neurotransmission .
loading...
    loading...
Cat. No.: HY-105774
CAS No.: 26629-87-8
Target:  

Serotonin Transporter

Research Areas:  

Neurological Disease

Oxaflozane is a non-tricyclic antidepressant with serotoninergic action. Oxaflozane has anti-cataleptic and anti-aggressive actions with a weak potentiation of the stereotypes provoked by Amphetamin .
loading...
    loading...
Cat. No.: HY-12390S
CAS No.: 1185083-78-6
Lofepramine-d3 (Lopramine-d3) is the deuterium labeled Lofepramine. Lofepramine (Lopramine) is a potent tricyclic antidepressant and is extensively metabolised to Desipramine. The antidepressant activity of Lofepramine stems from the facilitation of noradrenergic neurotransmission by uptake inhibition. Lofepramine may also potentiate serotoninergic neurotransmission by inhibition of the neuronal uptake of serotonin and the enzyme tryptophan pyrrolase. Lofepramine has significant anxiolytic efficacy in addition to its antidepressant properties .
loading...
    loading...
Cat. No.: HY-121203S6
Citalopram-d4 (oxalate) is the deuterium labeled Citalopram oxalate (HY-121203A). Citalopram is a racemate mixture of the active S(+)-enantiomer (Escitalopram; HY-14258) and R(-)-enantiomer. Citalopram is an orally active selective serotonin reuptake inhibitor (SSRI). Citalopram is an antidepressant and enhances serotoninergic neurotransmission .
loading...
    loading...
Cat. No.: HY-183927
CAS No.: 125141-02-8
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Spectramide is a blood-brain barrier-permeable, reversible, and selective dopamine D2 receptor ligand. Spectramide shows no strong interactions with dopamine D1 receptors, dopamine uptake sites, adrenergic receptor systems, cholinergic receptor systems, or 5-HTR systems. Spectramide can be labeled with 11C or 123I isotopes for use in PET or SPECT. Spectramide preferentially accumulates in the striatum with low uptake in other brain regions, and its accumulation can be blocked by pre-administration of Haloperidol (HY-14538) .
loading...
    loading...